“Molecular Defects” - targets for cancer therapy?
ASCO put out a page called “Targeting Molecular Defects May Be the Future of Cancer Therapy”. I don’t know about that choice of language - “molecular defects”? Are there such things? Anyway, the article is mostly about stem cells. Michael Clarke of Stanford pointed out that cancer stem cells may be used to diagnose metastasis in the future, and that treatments may target cancer stem cells. Jeremy Rich discussed the potential inhibition of CHK1 and CHK2 to target cancer stem cells, as the stem cells would be more susceptible than the tumor mass.
